Press Releases

Jan 20, 2022
Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022
Jan 10, 2022
Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference
Jan 06, 2022
Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic Research
Jan 05, 2022
Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants
Jan 04, 2022
Twist Bioscience to Present at the 40th Annual J.P. Morgan Healthcare Conference